CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia
Yongliang Liu(Army Medical University), Cheng Qian(Chongqing University)
Cited by 31
Related Papers
Sox9 regulates self‐renewal and tumorigenicity by promoting symmetrical cell division of cancer stem cells in hepatocellular carcinoma
|Hepatology|2016|153
IGF/STAT3/NANOG/Slug Signaling Axis Simultaneously Controls Epithelial-Mesenchymal Transition and Stemness Maintenance in Colorectal Cancer
|Stem Cells|2016|123
UBE2O promotes the proliferation, EMT and stemness properties of breast cancer cells through the UBE2O/AMPKα2/mTORC1-MYC positive feedback loop
|Cell Death and Disease|2020|93
Targeting vascular normalization: a promising strategy to improve immune–vascular crosstalk in cancer immunotherapy
|Frontiers in Immunology|2023|62